Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab

被引：0
|
作者：
Karth, Peter [1 ]
Moshfeghi, Darius M. [1 ]
Leng, Theodore [1 ]
机构：
[1] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
505; edema; 499 diabetic retinopathy; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1775
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
  • [2] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
    Lim, Laurence S.
    Ng, Wei Yan
    Mathur, Ranjana
    Wong, Doric
    Wong, Edmund Y. M.
    Yeo, Ian
    Cheung, Chui Ming Gemmy
    Lee, Shu Yen
    Wong, Tien Yin
    Papakostas, Thanos D.
    Kim, Leo A.
    [J]. CLINICAL OPHTHALMOLOGY, 2015, 9 : 1715 - 1718
  • [3] Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
    Alsaedi, Nasser G.
    Alselaimy, Ruba M.
    Alshamrani, Abdulaziz A.
    AlAjmi, Muhammed
    Khandekar, Rajiv
    Al-Dhibi, Hassan
    Al-Abdullah, Abdulelah A.
    [J]. CLINICAL OPHTHALMOLOGY, 2021, 15 : 2975 - 2980
  • [4] Comparative Effectiveness Trial of Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Sun, Jennifer K.
    [J]. DIABETES, 2015, 64 : A76 - A77
  • [5] Efficacy of Ranibizumab Therapy with Aflibercept in Patients with Diabetic Macular Edema
    Teixeira, Leonardo Pinheiro
    Dalia, Eduardo
    Campos, Luana
    Abrahao, Mayara Martins
    Nassaralla, Joao J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [6] Treatment of Diabetic Macular Edema with Aflibercept in Eyes with Previous Nonresponse to Ranibizumab and/or Bevacizumab
    Sadowsky, Rachel
    Quiram, Polly
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [7] Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
    Pessoa, Bernardete
    Malheiro, Luisa
    Carneiro, Ines
    Monteiro, Silvia
    Coelho, Joao
    Coelho, Constanca
    Figueira, Joao
    Meireles, Angelina
    Melo Beirao, Joao Nuno
    [J]. CLINICAL OPHTHALMOLOGY, 2021, 15 : 253 - 260
  • [8] Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Wood, Edward H.
    Karth, Peter A.
    Moshfeghi, Darius M.
    Leng, Theodore
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (09): : 950 - 954
  • [9] Short-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab
    Ores, Raphaelle
    Philippakis, Elise
    Massin, Pascale G.
    Tadayoni, Ramin
    Dupas, Benedicte Marie
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [10] Comparison of intravitreal ranibizumab, aflibercept and bevacizumab therapies in diabetic macular edema with serous retinal detachment
    Sirakaya, Ender
    Kilic, Deniz
    Sirakaya, Hatice Aslan
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (03) : 1459 - 1466
12345